Author:
Kuznetsov A. S.,Moiseenko A. V.,Kulikov E. E.,Letarov A. V.
Reference18 articles.
1. Allison, H.E., Sergeant, M.J., James, C.E., Saunders, J.R., Smith, D.L., Sharp, R.J., Marks, T.S., and McCarthy, A.J., Immunity profiles of wild-type and recombinant shiga-like toxin-encoding bacteriophages and characterization of novel double lysogens, Infect. Immun., 2003, vol. 71, no. 6, pp. 3409‒3418.
2. Blake, K.S., Choi, J., and Dantas, G., Approaches for characterizing and tracking hospital-associated multidrug-resistant bacteria, Cell Mol. Life Sci., 2021, vol. 78, no. 6, pp. 2585‒2606.
3. Callaway, T.R., Carr, M.A., Edrington, T.S., Anderson, R.C., and Nisbet, D.J., Diet, Escherichia coli O157:H7, and cattle: a review after 10 years, Curr. Iss. Mol. Biol., 2009, vol. 11, no. 2, pp. 67‒79.
4. de Oliveira, G.A. and Silva, J.L., Cryo-EM to visualize the structural organization of viruses, Curr. Opin. Virol., 2021, vol. 49, pp. 86‒91.
5. Freedman, S.B., Xie, J., Neufeld, M.S., Hamilton, W.L., Hartling, L., Tarr, P.I., Alberta Provincial Pediatric Enteric Infection Team, Nettel-Aguirre, A., Chuck, A., Lee, B., Johnson, D., Currie, G., Talbot, J., Jiang, J., Dickinson, J., et al., Shiga toxin-producing Escherichia coli infection, antibiotics, and risk of developing hemolytic uremic syndrome: a meta-analysis, Clin. Infect. Dis., 2016, vol. 62, no. 10, pp. 1251‒1258.